Back to Home
Featured

Directions in Oncology Pharmacy® 2025: Northeast

Saturday, November 15, 2025

Countdown to Event

00

Days

00

Hours

00

Mins

00

Secs

Stream Link: https://event.arraylive.com/app/login/f888a2c8-37e7-48db-9cb3-7c6ce3717fe8/virtualattendee

The landscape of oncology pharmacy continues to evolve with the approvals of immunotherapies and targeted therapies that are reshaping treatment paradigms across tumor types. This year’s Directions in Oncology Pharmacy® conference will explore timely advancements and practical strategies relevant to pharmacists in all oncology practice settings. Updates in various solid and hematologic malignancies will highlight how evolving clinical evidence is informing precision approaches to care. Expert-led sessions will also cover novel treatment approaches, offering insights into the next frontier of immune-based treatment, as well as the expanding role and associated toxicities of antibody-drug conjugates (ADCs) and PI3K/AKT pathway inhibitors, underscoring the increasing complexity of managing oral oncolytics.

This need for coordination of care across pharmacy settings has reinforced the roles of oncology pharmacists both clinically and operationally. It is essential for pharmacists to understand the different treatment options and dosing regimens, implement methods to improve patient adherence, educate other health care team members, and counsel patients during onboarding and ongoing treatment to manage potential adverse effects associated with these agents to optimize care and outcomes in patients with cancer. Designed to promote real-world application, the program combines didactic presentations with case-based discussions to support oncology pharmacists in optimizing therapy selection, monitoring, and providing education across the patient’s treatment journey.